Search
Kenvue Inc
KVUEAdd to Watchlist
18.395USD
+0.535+3.00%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
35.32BMarket Cap
21.75P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+3.00%
5 Days
+0.79%
1 Month
+4.93%
6 Months
+8.08%
Year to Date
+6.64%
1 Year
-14.00%
Key Figures
18.060Open
18.440High
13.46MVolume
21.75P/E TTM
14.40P/E Dynamic
0.828Dividend TTM
0.70%Turnover Ratio
17.860Prev. Close
17.990Low
117.78MTurnover
34.29P/E Static
3.33P/B
4.50%Div Yield TTM
6.11%ROA
23.90052wk High
0.66Volume Ratio
1.03BNet Profit
1.92BShares
0.8457EPS TTM
--Beta
15.70%ROE
14.02052wk Low
2.52%Amplitude
59.15%Gross Margin
35.32BMarket Cap
1.02Reward/Risk
1.84%Risk Rate
TradingKey Stock Score of Kenvue Inc
Currency: USD Updated: 2026-06-22Key Insights
Kenvue Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 35 in the Personal & Household Products & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 19.70.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Kenvue Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Kenvue Inc Highlights
StrengthsRisks
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 150.68%.
Undervalued
The company’s latest PE is 21.12, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.82B shares, decreasing 9.72% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 10.72M shares of this stock.
Analyst Rating
Based on
14
analysts
Hold
Current Rating
19.701
Target Price
+10.31%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Kenvue Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Kenvue Inc Info
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Ticker SymbolKVUE
CompanyKenvue Inc
CEOPerry (Kirk L)
Websitehttps://www.kenvue.com
Related Instruments
+2.16%
+2.69%
+3.11%
+3.43%
-0.95%
+2.92%
+2.30%
+1.01%
+1.86%
+2.86%
+2.08%
+5.36%
+2.91%
+1.71%
+1.83%
+1.44%
0.00%
+1.47%
+0.69%Popular Instruments
72.812
-0.133 (-0.18%)
294.300
-2.710 (-0.91%)
200.040
-8.610 (-4.13%)
4099.880
-10.870 (-0.26%)
670.750
-61.870 (-8.45%)
1961.070
-312.660 (-13.75%)
1051.770
-159.610 (-13.18%)
346.130
-3.550 (-1.02%)
62535.350
+94.650 (+0.15%)
381.610
-23.440 (-5.79%)
FAQs
What is the current price of Kenvue Inc (KVUE)?
The current price of Kenvue Inc (KVUE) is 17.86.
What is the symbol of Kenvue Inc?
The ticker symbol of Kenvue Inc is KVUE.
What is the 52-week high of Kenvue Inc?
The 52-week high of Kenvue Inc is 23.90.
What is the 52-week low of Kenvue Inc?
The 52-week low of Kenvue Inc is 14.02.
What is the market capitalization of Kenvue Inc?
The market capitalization of Kenvue Inc is 34.29B.
Is Kenvue Inc (KVUE) currently rated as Buy, Hold, or Sell?
According to analysts, Kenvue Inc (KVUE) has an overall rating of signal_hold, with a price target of 19.70.
What is the Earnings Per Share (EPS TTM) of Kenvue Inc (KVUE)?
The Earnings Per Share (EPS TTM) of Kenvue Inc (KVUE) is 0.77.
